Melissa Lee is director of the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF), where she leads the DxA’s AI portfolio, including SpeechDx. Her work at the ADDF focuses on scientific strategy, partnership development, and AI and digital biomarker innovation. Prior to the ADDF, Lee completed her PhD and postdoctoral studies at Columbia University, where she studied glial cells in autism and brain development under Drs. Carol Mason and Mimi Shirasu-Hiza.